{"id":"https://openalex.org/W2593411101","doi":"https://doi.org/10.1080/14656566.2017.1299710","title":"Can binimetinib, encorafenib and masitinib be more efficacious than currently available mutation-based targeted therapies for melanoma treatment?","display_name":"Can binimetinib, encorafenib and masitinib be more efficacious than currently available mutation-based targeted therapies for melanoma treatment?","publication_year":2017,"publication_date":"2017-03-03","ids":{"openalex":"https://openalex.org/W2593411101","doi":"https://doi.org/10.1080/14656566.2017.1299710","mag":"2593411101","pmid":"https://pubmed.ncbi.nlm.nih.gov/28277830"},"language":"en","primary_location":{"id":"doi:10.1080/14656566.2017.1299710","doi":"https://doi.org/10.1080/14656566.2017.1299710","is_oa":false,"landing_page_url":"https://doi.org/10.1080/14656566.2017.1299710","pdf_url":null,"source":{"id":"https://openalex.org/S52020611","display_name":"Expert Opinion on Pharmacotherapy","issn_l":"1465-6566","issn":["1465-6566","1744-7666"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Pharmacotherapy","raw_type":"journal-article"},"volume":null,"type":"review","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5001283281","display_name":"Megan C. Turner","orcid":"https://orcid.org/0000-0002-1235-1065","observed_orcids":["https://orcid.org/0000-0002-1235-1065"]},"institutions":[{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Megan C Turner","raw_affiliation_strings":["a Department of Surgery , Duke University , Durham , NC , USA","Department of Surgery, Duke University, Durham, NC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"a Department of Surgery , Duke University , Durham , NC , USA","institution_ids":["https://openalex.org/I170897317"]},{"raw_affiliation_string":"Department of Surgery, Duke University, Durham, NC, USA","institution_ids":["https://openalex.org/I170897317"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066074100","display_name":"Kara K. Rossfeld","orcid":"https://orcid.org/0000-0002-5240-7385","observed_orcids":["https://orcid.org/0000-0002-5240-7385"]},"institutions":[{"id":"https://openalex.org/I52357470","display_name":"The Ohio State University","ror":"https://ror.org/00rs6vg23","country_code":"US","type":"education","lineage":["https://openalex.org/I52357470"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kara Rossfeld","raw_affiliation_strings":["b Department of Surgery , Ohio State University , Columbus , OH , USA","Department of Surgery, Ohio State University, Columbus, OH, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"b Department of Surgery , Ohio State University , Columbus , OH , USA","institution_ids":["https://openalex.org/I52357470"]},{"raw_affiliation_string":"Department of Surgery, Ohio State University, Columbus, OH, USA","institution_ids":["https://openalex.org/I52357470"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090769354","display_name":"April K.S. Salama","orcid":"https://orcid.org/0000-0002-8105-5374","observed_orcids":["https://orcid.org/0000-0002-8105-5374"]},"institutions":[{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"April K.S Salama","raw_affiliation_strings":["c Department of Medicine , Duke University , Durham , NC , USA","Department of Medicine, Duke University, Durham, NC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"c Department of Medicine , Duke University , Durham , NC , USA","institution_ids":["https://openalex.org/I170897317"]},{"raw_affiliation_string":"Department of Medicine, Duke University, Durham, NC, USA","institution_ids":["https://openalex.org/I170897317"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015827608","display_name":"Douglas S. Tyler","orcid":"https://orcid.org/0000-0002-7434-846X","observed_orcids":["https://orcid.org/0000-0002-7434-846X"]},"institutions":[{"id":"https://openalex.org/I55302922","display_name":"The University of Texas Medical Branch at Galveston","ror":"https://ror.org/016tfm930","country_code":"US","type":"education","lineage":["https://openalex.org/I55302922"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Douglas Tyler","raw_affiliation_strings":["d Department of Surgery , University of Texas Medical Branch at Galveston , Galveston , TX , USA","Department of Surgery, University of Texas Medical Branch at Galveston, Galveston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"d Department of Surgery , University of Texas Medical Branch at Galveston , Galveston , TX , USA","institution_ids":["https://openalex.org/I55302922"]},{"raw_affiliation_string":"Department of Surgery, University of Texas Medical Branch at Galveston, Galveston, TX, USA","institution_ids":["https://openalex.org/I55302922"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5050528758","display_name":"Georgia Marie Beasley","orcid":"https://orcid.org/0000-0001-6387-9030","observed_orcids":["https://orcid.org/0000-0001-6387-9030"]},"institutions":[{"id":"https://openalex.org/I52357470","display_name":"The Ohio State University","ror":"https://ror.org/00rs6vg23","country_code":"US","type":"education","lineage":["https://openalex.org/I52357470"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Georgia Beasley","raw_affiliation_strings":["b Department of Surgery , Ohio State University , Columbus , OH , USA","Department of Surgery, Ohio State University, Columbus, OH, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"b Department of Surgery , Ohio State University , Columbus , OH , USA","institution_ids":["https://openalex.org/I52357470"]},{"raw_affiliation_string":"Department of Surgery, Ohio State University, Columbus, OH, USA","institution_ids":["https://openalex.org/I52357470"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5050528758"],"corresponding_institution_ids":["https://openalex.org/I52357470"],"apc_list":null,"apc_paid":null,"fwci":0.1293,"has_fulltext":false,"cited_by_count":8,"citation_normalized_percentile":{"value":0.09034235,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"18","issue":"5","first_page":"487","last_page":"495"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10392","display_name":"Cutaneous Melanoma Detection and Management","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/binimetinib","display_name":"binimetinib","score":0.9369999766349792},{"id":"https://openalex.org/keywords/encorafenib","display_name":"encorafenib","score":1.0},{"id":"https://openalex.org/keywords/masitinib","display_name":"masitinib","score":1.0},{"id":"https://openalex.org/keywords/metastatic-melanoma","display_name":"metastatic melanoma","score":0.9700000286102295},{"id":"https://openalex.org/keywords/braf-inhibitors","display_name":"BRAF inhibitors","score":0.9089999794960022},{"id":"https://openalex.org/keywords/mek-inhibitors","display_name":"MEK inhibitors","score":0.8889999985694885},{"id":"https://openalex.org/keywords/c-kit-inhibitors","display_name":"c-KIT inhibitors","score":0.9139999747276306},{"id":"https://openalex.org/keywords/targeted-therapy","display_name":"targeted therapy","score":0.8209999799728394},{"id":"https://openalex.org/keywords/braf-mutation","display_name":"BRAF mutation","score":0.746999979019165},{"id":"https://openalex.org/keywords/kit-mutations","display_name":"KIT mutations","score":0.8029999732971191},{"id":"https://openalex.org/keywords/nras-mutation","display_name":"NRAS mutation","score":0.8759999871253967},{"id":"https://openalex.org/keywords/personalized-medicine","display_name":"personalized medicine","score":0.503000020980835}],"concepts":[{"id":"https://openalex.org/C21790070","wikidata":"https://www.wikidata.org/wiki/Q18030215","display_name":"Neuroblastoma RAS viral oncogene homolog","level":5,"score":0.8612402081489563},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8391823768615723},{"id":"https://openalex.org/C2994587330","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Metastatic melanoma","level":3,"score":0.6413124203681946},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.6386675834655762},{"id":"https://openalex.org/C2781230642","wikidata":"https://www.wikidata.org/wiki/Q492646","display_name":"Targeted therapy","level":3,"score":0.4903247654438019},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.48536574840545654},{"id":"https://openalex.org/C2781249067","wikidata":"https://www.wikidata.org/wiki/Q17142288","display_name":"MEK inhibitor","level":4,"score":0.4851608872413635},{"id":"https://openalex.org/C2776131300","wikidata":"https://www.wikidata.org/wiki/Q423111","display_name":"Vemurafenib","level":4,"score":0.4719858765602112},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3416460156440735},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.33607202768325806},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.25793975591659546},{"id":"https://openalex.org/C57074206","wikidata":"https://www.wikidata.org/wiki/Q14197552","display_name":"MAPK/ERK pathway","level":3,"score":0.20696917176246643},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.09129318594932556},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.0693097710609436},{"id":"https://openalex.org/C2781187634","wikidata":"https://www.wikidata.org/wiki/Q20969980","display_name":"KRAS","level":4,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D001549","descriptor_name":"Benzamides","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001562","descriptor_name":"Benzimidazoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D002219","descriptor_name":"Carbamates","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009154","descriptor_name":"Mutation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010880","descriptor_name":"Piperidines","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011725","descriptor_name":"Pyridines","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012878","descriptor_name":"Skin Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D013449","descriptor_name":"Sulfonamides","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D013844","descriptor_name":"Thiazoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D019009","descriptor_name":"Proto-Oncogene Proteins c-kit","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D040901","descriptor_name":"Proteomics","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D048493","descriptor_name":"Proto-Oncogene Proteins B-raf","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1080/14656566.2017.1299710","doi":"https://doi.org/10.1080/14656566.2017.1299710","is_oa":false,"landing_page_url":"https://doi.org/10.1080/14656566.2017.1299710","pdf_url":null,"source":{"id":"https://openalex.org/S52020611","display_name":"Expert Opinion on Pharmacotherapy","issn_l":"1465-6566","issn":["1465-6566","1744-7666"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Pharmacotherapy","raw_type":"journal-article"},{"id":"pmid:28277830","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/28277830","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert opinion on pharmacotherapy","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9763000011444092}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":84,"referenced_works":["https://openalex.org/W1804117510","https://openalex.org/W1819015028","https://openalex.org/W1950572133","https://openalex.org/W1965370740","https://openalex.org/W1967902354","https://openalex.org/W1977914780","https://openalex.org/W1988379285","https://openalex.org/W1989121777","https://openalex.org/W1996405087","https://openalex.org/W1998028009","https://openalex.org/W2004295816","https://openalex.org/W2026524381","https://openalex.org/W2032211985","https://openalex.org/W2034048944","https://openalex.org/W2040286515","https://openalex.org/W2040956995","https://openalex.org/W2043058822","https://openalex.org/W2044297092","https://openalex.org/W2052735666","https://openalex.org/W2054918837","https://openalex.org/W2064969209","https://openalex.org/W2065620201","https://openalex.org/W2071525523","https://openalex.org/W2079398727","https://openalex.org/W2081797247","https://openalex.org/W2086010484","https://openalex.org/W2089228335","https://openalex.org/W2089553218","https://openalex.org/W2094481139","https://openalex.org/W2096027620","https://openalex.org/W2096223992","https://openalex.org/W2097995306","https://openalex.org/W2099044540","https://openalex.org/W2100969832","https://openalex.org/W2103152130","https://openalex.org/W2103557568","https://openalex.org/W2104788624","https://openalex.org/W2106986615","https://openalex.org/W2112468133","https://openalex.org/W2115562945","https://openalex.org/W2116978375","https://openalex.org/W2118084349","https://openalex.org/W2121545342","https://openalex.org/W2128542677","https://openalex.org/W2134471382","https://openalex.org/W2136474966","https://openalex.org/W2145657367","https://openalex.org/W2147474070","https://openalex.org/W2147630681","https://openalex.org/W2149642154","https://openalex.org/W2154841567","https://openalex.org/W2155111125","https://openalex.org/W2155461614","https://openalex.org/W2156078931","https://openalex.org/W2156266404","https://openalex.org/W2160181672","https://openalex.org/W2160766792","https://openalex.org/W2166262263","https://openalex.org/W2166662937","https://openalex.org/W2169829719","https://openalex.org/W2170065082","https://openalex.org/W2188476586","https://openalex.org/W2203677081","https://openalex.org/W2207662183","https://openalex.org/W2213168510","https://openalex.org/W2220812108","https://openalex.org/W2239758289","https://openalex.org/W2293206859","https://openalex.org/W2320842203","https://openalex.org/W2337203560","https://openalex.org/W2405027107","https://openalex.org/W2416204731","https://openalex.org/W2481233565","https://openalex.org/W2491982852","https://openalex.org/W2507950939","https://openalex.org/W2515022710","https://openalex.org/W2518470597","https://openalex.org/W2520540679","https://openalex.org/W2529349414","https://openalex.org/W2562120582","https://openalex.org/W2590203198","https://openalex.org/W2591388111","https://openalex.org/W2602918057","https://openalex.org/W4255292957"],"related_works":["https://openalex.org/W3008022698","https://openalex.org/W2904243030","https://openalex.org/W4281876995","https://openalex.org/W2751176308","https://openalex.org/W3015032733","https://openalex.org/W2941768756","https://openalex.org/W3081781645","https://openalex.org/W2039425268","https://openalex.org/W7212064356","https://openalex.org/W2909618481"],"abstract_inverted_index":{"INTRODUCTION:":[0],"Historically,":[1],"there":[2],"were":[3],"few":[4],"effective":[5],"and":[6,20,33,57,79,111],"durable":[7],"treatments":[8],"for":[9,22,42,62,95],"metastatic":[10,25],"melanoma.":[11,26],"Recently,":[12],"mutation":[13],"based":[14],"targeted":[15],"therapies":[16],"have":[17,93],"revolutionized":[18],"treatment":[19,41],"outcomes":[21],"patients":[23,43],"with":[24],"Specifically,":[27],"inhibitors":[28,59],"aimed":[29],"at":[30],"BRAF,":[31,55],"NRAS,":[32,56],"C-KIT":[34,58],"mutations":[35],"are":[36],"now":[37],"commonly":[38],"used":[39],"in":[40,97],"harboring":[44],"the":[45,87],"specific":[46],"mutations.":[47],"Areas":[48],"covered:":[49],"A":[50],"brief":[51],"review":[52,65],"of":[53,66],"current":[54],"provides":[60],"background":[61],"a":[63,72,76,104],"thorough":[64],"newly":[67],"developed":[68],"agents":[69,90],"namely":[70],"binimetinib,":[71],"MEK":[73],"inhibitor,":[74,78],"encorafenib":[75],"BRAF":[77],"masitinib":[80],"which":[81],"inhibits":[82],"C-KIT.":[83],"Expert":[84],"opinion:":[85],"While":[86],"3":[88],"novel":[89],"reviewed":[91],"here":[92],"potential":[94],"use":[96],"melanoma,":[98],"optimal":[99],"utilization":[100],"will":[101],"occur":[102],"once":[103],"more":[105],"personalized":[106],"approach":[107],"incorporating":[108],"genomic,":[109],"proteomic,":[110],"immunologic":[112],"data":[113],"guides":[114],"therapeutic":[115],"decisions.":[116]},"counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":3}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2017-03-16T00:00:00"}